Skip to main navigation Skip to search Skip to main content

Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology (Nature Cancer, (2022), 3, 2, (251-261), 10.1038/s43018-022-00332-x)

  • Cancer Core Europe consortium

Research output: Contribution to journalComment/debate

4 Scopus citations

Abstract

In this article, the Code availability section has been updated to clarify conditions for access and to revise the repository link. The new statement now reads “Aggregated results shown in this article were created using Python (>3.5) NumPy, Pandas and Matplotlib open-source libraries. The code for the MTBP components reproducing the variant annotation framework discussed in the manuscript has been deposited to Zenodo with access restricted for research use only (see https://doi.org/10.5281/zenodo.6376428 for terms of use details). Access to other components available in MTBP production systems can be provided upon agreement with the copyright holders.” The change has been made in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)649
Number of pages1
JournalNature Cancer
Volume3
Issue number5
DOIs
StatePublished - May 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology (Nature Cancer, (2022), 3, 2, (251-261), 10.1038/s43018-022-00332-x)'. Together they form a unique fingerprint.

Cite this